In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses

Autologous tumor cell vaccines can elicit anti-tumor immune responses. Here, the authors report the design of dendritic polymer-based nanoparticles loaded with doxorubicin and the tyrosine kinase inhibitor apatinib that can induce immunogenic cell death and the in situ production of immuno-stimulato...

Full description

Bibliographic Details
Main Authors: Yuxin Guo, Shao-Zhe Wang, Xinping Zhang, Hao-Ran Jia, Ya-Xuan Zhu, Xiaodong Zhang, Ge Gao, Yao-Wen Jiang, Chengcheng Li, Xiaokai Chen, Shun-Yu Wu, Yi Liu, Fu-Gen Wu
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-33831-7
_version_ 1811223544831410176
author Yuxin Guo
Shao-Zhe Wang
Xinping Zhang
Hao-Ran Jia
Ya-Xuan Zhu
Xiaodong Zhang
Ge Gao
Yao-Wen Jiang
Chengcheng Li
Xiaokai Chen
Shun-Yu Wu
Yi Liu
Fu-Gen Wu
author_facet Yuxin Guo
Shao-Zhe Wang
Xinping Zhang
Hao-Ran Jia
Ya-Xuan Zhu
Xiaodong Zhang
Ge Gao
Yao-Wen Jiang
Chengcheng Li
Xiaokai Chen
Shun-Yu Wu
Yi Liu
Fu-Gen Wu
author_sort Yuxin Guo
collection DOAJ
description Autologous tumor cell vaccines can elicit anti-tumor immune responses. Here, the authors report the design of dendritic polymer-based nanoparticles loaded with doxorubicin and the tyrosine kinase inhibitor apatinib that can induce immunogenic cell death and the in situ production of immuno-stimulatory micrometer-sized vesicles, promoting anti-tumor immune responses in preclinical models.
first_indexed 2024-04-12T08:34:25Z
format Article
id doaj.art-bd2998047de34de1a314192dca82111c
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-12T08:34:25Z
publishDate 2022-11-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-bd2998047de34de1a314192dca82111c2022-12-22T03:40:04ZengNature PortfolioNature Communications2041-17232022-11-0113112010.1038/s41467-022-33831-7In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responsesYuxin Guo0Shao-Zhe Wang1Xinping Zhang2Hao-Ran Jia3Ya-Xuan Zhu4Xiaodong Zhang5Ge Gao6Yao-Wen Jiang7Chengcheng Li8Xiaokai Chen9Shun-Yu Wu10Yi Liu11Fu-Gen Wu12State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityState Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast UniversityAutologous tumor cell vaccines can elicit anti-tumor immune responses. Here, the authors report the design of dendritic polymer-based nanoparticles loaded with doxorubicin and the tyrosine kinase inhibitor apatinib that can induce immunogenic cell death and the in situ production of immuno-stimulatory micrometer-sized vesicles, promoting anti-tumor immune responses in preclinical models.https://doi.org/10.1038/s41467-022-33831-7
spellingShingle Yuxin Guo
Shao-Zhe Wang
Xinping Zhang
Hao-Ran Jia
Ya-Xuan Zhu
Xiaodong Zhang
Ge Gao
Yao-Wen Jiang
Chengcheng Li
Xiaokai Chen
Shun-Yu Wu
Yi Liu
Fu-Gen Wu
In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
Nature Communications
title In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
title_full In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
title_fullStr In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
title_full_unstemmed In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
title_short In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
title_sort in situ generation of micrometer sized tumor cell derived vesicles as autologous cancer vaccines for boosting systemic immune responses
url https://doi.org/10.1038/s41467-022-33831-7
work_keys_str_mv AT yuxinguo insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT shaozhewang insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT xinpingzhang insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT haoranjia insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT yaxuanzhu insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT xiaodongzhang insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT gegao insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT yaowenjiang insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT chengchengli insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT xiaokaichen insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT shunyuwu insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT yiliu insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses
AT fugenwu insitugenerationofmicrometersizedtumorcellderivedvesiclesasautologouscancervaccinesforboostingsystemicimmuneresponses